Voltage-gated sodium channels: The search for subtype-selective analgesics

Expert Opinion on Investigational Drugs

Volumn 17, Issue 12, 2008, Pages 1849-1864

  England, Steve ^a  

^a PFIZER INC   (United States)

Author keywords

Modulator; Pain; Pharmacology; Primary afferent; Voltage gated sodium channel

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; VOLTAGE GATED SODIUM CHANNEL; SODIUM CHANNEL;

ANTIARRHYTHMIC ACTIVITY; ATAXIA; BLURRED VISION; BRAIN; CLINICAL EFFECTIVENESS; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TARGETING; HEART; HUMAN; INNERVATION; MUSCLE SPINDLE AFFERENT NERVE; NAUSEA; NEUROMODULATION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SOMNOLENCE; STRUCTURAL HOMOLOGY; ANIMAL; CHANNEL GATING; CLASSIFICATION; DRUG EFFECT; GENETICS; METABOLISM; MUTATION;

ANALGESICS; ANIMALS; HUMANS; ION CHANNEL GATING; MUTATION; PAIN; SODIUM CHANNELS;

EID: 58149385667     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780802514559     Document Type: Review

References (146)

1. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001;63:871-894 (Pubitemid 32304340)
2. Goldin AL. Evolution of voltage-gated Na(+) channels. J Exp Biol 2002;205(5):575-584 (Pubitemid 34861094)
3. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005;57(4):397-409 • Excellent review providing background on many aspects of VGSCs.
4. Tibbs VC, Gray PC, Catterall WA, Murphy BJ. AKAP15 anchors cAMP-dependent protein kinase to brain sodium channels. J Biol Chem 1998;273(40):25783-25788 (Pubitemid 28475805)
5. Cantrell AR, Tibbs VC, Yu FH, et al. Molecular mechanism of convergent regulation of brain Na(+) channels by protein kinase C and protein kinase A anchored to AKAP-15. Mol Cell Neurosci 2002;21(1):63-80 (Pubitemid 35178500)
6. Catterall WA, Hulme JT, Jiang X, Few WP. Regulation of sodium and calcium channels by signaling complexes. J Recept Signal Transduct Res 2006;26(5-6):577-598 (Pubitemid 44849906)
7. Rohl CA, Boeckman FA, Baker C, et al. Solution structure of the sodium channel inactivation gate. Biochemistry 1999;38(3):855-861 (Pubitemid 29052698)
8. Tseng TT, McMahon AM, Johnson VT, et al. Sodium channel auxiliary subunits. J Mol Microbiol Biotechnol 2007;12(3-4):249-262 (Pubitemid 46991598)
9. Hille B. Ionic Channels of Excitable Membranes, 2nd edtion. Sunderland, MA: Sinauer Associates; 1992
10. Black JA, Dib-Hajj S, McNabola K, et al. Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res Mol Brain Res 1996;43(1-2):117-131 • Very important study, one of the first to describe the diversity of VGSCs in DRGs. (Pubitemid 27042398)
11. Dib-Hajj SD, Fjell J, Cummins TR, et al. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 1999;83(3):591-600
12. Waxman SG, Kocsis JD, Black JA. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 1994;72(1):466-470 (Pubitemid 24233666)
13. Cummins TR, Waxman SG. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 1997;17(10):3503-3514 (Pubitemid 27200579)
14. Lindia JA, Köhler MG, Martin WJ, Abbadie C. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Pain 2005;117(1-2):145-153 (Pubitemid 41764782)
15. Nassar MA, Baker MD, Levato A, et al. Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain 2006;2:33 doi:10.1186/1744-8069-2-33 (Pubitemid 44741732)
16. Cummins TR, Aglieco F, Renganathan M, et al. Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 2001;21(16):5952-5961 (Pubitemid 32737728)
17. Chen YH, Dale TJ, Romanos MA, et al. Cloning, distribution and functional analysis of the type III sodium channel from human brain. Eur J Neurosci 2000;12(12):4281-4289 (Pubitemid 32040926)
18. Whitaker WR, Faull RL, Waldvogel HJ, et al. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res 2001;88(1-2):37-53 (Pubitemid 32274258)
19. Whitaker WR, Clare JJ, Powell AJ, et al. Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J Comp Neurol 2000;422(1):123-139 (Pubitemid 30346568)
20. Hains BC, Klein JP, Saab CY, et al. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 2003;23(26):8881-8892 (Pubitemid 37210901)
21. Nassar MA, Stirling LC, Forlani G, et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci USA 2004;101(34):12706-12711 (Pubitemid 39122087)
22. Nassar MA, Levato A, Stirling LC, Wood JN. Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol Pain 2005;1:24 doi:10.1186/1744-8069-1-24
23. Luo S, Perry GM, Levinson SR, Henry MA. Nav1.7 expression is increased in painful human dental pulp. Mol Pain 2008;4:16 doi:10.1186/1744-8069-4-16 (Pubitemid 351689722)
24. Keh SM, Facer P, Simpson KD, et al. Increased nerve fiber expression of sensory sodium channels Nav1.7, Nav1.8, and Nav1.9 in rhinitis. Laryngoscope 2008;118(4):573-579
25. Losa M, Scheier H, Rohner P, et al. Long-term course in congenital analgesia Schweiz Med Wochenschr 1989;119(38):1303-1308
26. Hirsch E, Moye D, Dimon JH III. Congenital indifference to pain: long-term follow-up of two cases. South Med J 1995;88(8):851-857
27. Dearborn GVN. A case of congenital pure analgesia. Nerv Ment Dis 1932;75;612-615 • One of the earliest clinical descriptions of CIP. Very worthwhile reading because of the colourful description of the condition.
28. Manfredi M, Bini G, Cruccu G, et al. Congenital absence of pain. Arch Neurol 1981;38(8):507-511 (Pubitemid 11046569)
29. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006;444(7121):894-898 •• Very important paper, the first description of the genetic basis of CIP linking it to mutations in Nav1.7. (Pubitemid 46024997)
30. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007;71(4):311-19 •• Similar to the Cox et al. study [29] but more extensive, including data from nine families of seven different nationalities. (Pubitemid 46690905)
31. Ahmad S, Dahllund L, Eriksson AB, et al. A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet 2007;16(17):2114-2121 (Pubitemid 47354894)
32. Brown GF. Erythromelalgia and other disturbances of the extremities accompanied by vasodilatation and burning. Am J Med Sci 1932;183:468-485
33. Widmann RR. Erythermalgia; report of a case, and response to a new therapeutic approach. Calif Med 1949;71(5):356-359
34. Babb RR, Alarcon-Segovia D, Fairbairn JF II. Erythermalgia: review of 51 cases. Circulation 1964;29:136-141
35. Drenth JP, Michiels JJ. Clinical characteristics and pathophysiology of erythromelalgia and erythermalgia. Am J Med 1992;93(1):111-114
36. Drenth JP, Te Morsche RH, Mansour S, Mortimer PS. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A. Arch Dermatol 2008;144(3):320-324
37. Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 2004;24(38):8232-8236 • One of the first studies demonstrating the effects of erythermalgia mutations on biophysical properties of Nav1.7 currents. (Pubitemid 39280802)
38. Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005;128(8):1847-1854 • Biophysical study showing the effect of erythermalgia mutants on DRG excitability. (Pubitemid 41373656)
39. Michiels JJ, te Morsche RH, Jansen JB, Drenth JP. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol 2005;62(10):1587-1590
40. Lampert A, Dib-Hajj SD, Tyrrell L, Waxman SG. Size matters: erythromelalgia mutation S241T in Nav1.7 alters channel gating. J Biol Chem 2006;281(47):36029-36035 (Pubitemid 46041336)
41. Choi JS, Dib-Hajj SD, Waxman SG. Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy. Neurology 2006;67(9):1563-1567 (Pubitemid 44747924)
42. Harty TP, Dib-Hajj SD, Tyrrell L, et al. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J Neurosci 2006;26(48):12566-12575
43. Lampert A, O'Reilly AO, Dib-Hajj SD, et al. A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Nav1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation. J Biol Chem 2008;283(35):24118-24127 [Epub ahead of print]
44. Cheng X, Dib-Hajj SD, Tyrrell L, Waxman SG. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade. Mol Pain 2008;4:1 doi:10.1186/1744- 8069-4-1
45. Han C, Rush AM, Dib-Hajj SD, et al. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 2006;59(3):553-558 (Pubitemid 43358077)
46. Han C, Lampert A, Rush AM, et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain 2007;3:3 doi:10.1186/1744-8069-3-3 (Pubitemid 46211001)
47. Sheets PL, Jackson JO II, Waxman SG, et al. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol 2007;581(3):1019-1031 (Pubitemid 46887978)
48. Drenth JP, Waxman SG. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest 2007;117(12):3603-3609 • Excellent review providing state-of-the-art knowledge concerning the Nav1.7 mutations and associated clinical conditions. (Pubitemid 350224065)
49. Cummins TR, Howe JR, Waxman SG. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 1998;18(23):9607-9619 (Pubitemid 28543742)
50. Waxman SG. Neurobiology: a channel sets the gain on pain. Nature 2006;444(7121):831-832 (Pubitemid 46024984)
51. Toledo-Aral JJ, Moss BL, He ZJ, et al. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci USA 1997;94(4):1527-1532 (Pubitemid 27087885)
52. Rush AM, Dib-Hajj SD, Liu S, et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci USA 2006;103(21):8245-8250 (Pubitemid 43801083)
53. Mørk C, Kalgaard OM, Kvernebo K. Impaired neurogenic control of skin perfusion in erythromelalgia. J Invest Dermatol 2002;118(4):699-703 (Pubitemid 34309992)
54. Fertleman CR, Ferrie CD. What's in a name? Familial rectal pain syndrome becomes paroxysmal extreme pain disorder. J Neurol Neurosurg Psychiatry 2006;77(11):1294-1295 (Pubitemid 44654770)
55. Hayden R, Grossman M. Rectal, ocular, and submaxillary pain; a familial autonomic disorder related to proctalgia fugaz: report of a family. AMA J Dis Child 1959;97(4):479-482
56. Fertleman CR, Ferrie CD, Aicardi J, et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology 2007;69(6):586-595 (Pubitemid 47357266)
57. Schubert R, Cracco JB. Familial rectal pain: a type of reflex epilepsy? Ann Neurol 1992;32(6):824-826
58. Yiangou Y, Facer P, Chessell IP, et al. Voltage-gated ion channel Nav1.7 innervation in patients with idiopathic rectal hypersensitivity and paroxysmal extreme pain disorder (familial rectal pain). Neurosci Lett 2007;427(2):77-82 (Pubitemid 47633792)
59. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006;52(5):767-774 • First description of mutations associated with PEPD. (Pubitemid 44828442)
60. Jarecki BW, Sheets PL, Jackson Ii JO, Cummins TR. Paroxysmal extreme pain disorder mutations within the D3/S4-S5 Linker of Nav1.7 cause moderate destabilization of fast-inactivation. J Physiol 2008;[Epub ahead of print]
61. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996;379(6562):257-262 (Pubitemid 26025211)
62. Akopian AN, Souslova V, England S, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999;2(6):541-548 (Pubitemid 30491235)
63. Amaya F, Decosterd I, Samad TA, et al. Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol Cell Neurosci 2000;15(4):331-342 (Pubitemid 30266270)
64. Sivilotti L, Okuse K, Akopian AN, et al. A single serine residue confers tetrodotoxin insensitivity on the rat sensory-neuron-specific sodium channel SNS. FEBS Lett 1997;409(1):49-52 (Pubitemid 27248565)
65. O'Brien BJ, Caldwell JH, Ehring GR, et al. Tetrodotoxin-resistant voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 are expressed in the retina. J Comp Neurol 2008;508(6):940-951 • This paper describes Nav1.8 and 1.9 in mouse retina. Is this relevant in man, and is it a possible safety concern for compounds active at these channels?
66. Ogata N, Tatebayashi H. Kinetic analysis of two types of Na+ channels in rat dorsal root ganglia. J Physiol 1993;466:9-37 (Pubitemid 23225215)
67. Elliott AA, Elliott JR. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol 1993;463:39-56 (Pubitemid 23120575)
68. Rush AM, Bräu ME, Elliott AA, Elliott JR. Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol 1998;511(3):771-789 (Pubitemid 28456906)
69. Blair NT, Bean BP. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 2002;22(23):10277-10290 (Pubitemid 35416866)
70. Zimmermann K, Leffler A, Babes A, et al. Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature 2007;447(7146):855-858 (Pubitemid 46920141)
71. Quasthoff S, Grosskreutz J, Schröder JM, et al. Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience 1995;69(3):955-965
72. Jeftinija S. The role of tetrodotoxin-resistant sodium channels of small primary afferent fibers. Brain Res 1994;639(1):125-134 (Pubitemid 24067443)
73. Brock JA, McLachlan EM, Belmonte C. Tetrodotoxin-resistant impulses in single nociceptor nerve terminals in guinea-pig cornea. J Physiol 1998;512(1):211-217 • First description of TTX-resistance generator potentials in the fine terminals of nociceptors. (Pubitemid 28477429)
74. Strassman AM, Raymond SA. Electrophysiological evidence for tetrodotoxin-resistant sodium channels in slowly conducting dural sensory fibers. J Neurophysiol 1999;81(2):413-424 (Pubitemid 29264489)
75. Catterall WA. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv Neurol 1999;79:441-456
76. England S, Bevan S, Docherty RJ. PGE2 modulates the tetrodotoxin- resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 1996;495(2):429-440 (Pubitemid 26331824)
77. Gold MS, Reichling DB, Shuster MJ, Levine JD. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci USA 1996;93(3):1108-1112 (Pubitemid 26052849)
78. Fitzgerald EM, Okuse K, Wood JN, et al. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol 1999;516(2):433-446 (Pubitemid 29204448)
79. Gold MS, Levine JD, Correa AM. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 1998;18(24):10345-10355 (Pubitemid 29016554)
80. Hudmon A, Choi JS, Tyrrell L, et al. Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 2008;28(12):3190-3201
81. Ma K, Zhou QH, Chen J, et al. TTX-R Na+ current-reduction by celecoxib correlates with changes in PGE2; and CGRP within rat DRG neurons during acute incisional pain. Brain Res 2008;1209:57-64
82. England S. Molecular basis of peripheral hyperalgesia. In: Wood JN, editor. Molecular basis of pain induction. New York: Wiley-Liss; 2000; p. 261-287
83. Abrahamsen B, Zhao J, Asante CO, et al. The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 2008;321(5889):702-705 • Authors used diphtheria toxin to selectively ablate Nav1.8-expressing nociceptors. Probably provides more useful information than conditional knockouts due to channel plasticity observed using conventional knockout approaches.
84. Lai J, Gold MS, Kim CS, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 2002;95(1-2):143-152 (Pubitemid 34076786)
85. Dib-Hajj SD, Black JA, Cummins TR, et al. Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo. J Neurophysiol 1998;79(5):2668-2676 (Pubitemid 28261650)
86. Fjell J, Cummins TR, Fried K, et al. In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. J Neurophysiol 1999;81(2):803-810
87. Fjell J, Cummins TR, Davis BM, et al. Sodium channel expression in NGF-overexpressing transgenic mice. J Neurosci Res 1999;57(1):39-47 (Pubitemid 29293578)
88. Coward K, Plumpton C, Facer P, et al. Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states. Pain 2000;85(1-2):41-50 (Pubitemid 30110742)
89. Coward K, Jowett A, Plumpton C, et al. Sodium channel beta1 and beta2 subunits parallel SNS/PN3 alpha-subunit changes in injured human sensory neurons. Neuroreport 2001;12(3):483-488 (Pubitemid 32173952)
90. Renton T, Yiangou Y, Plumpton C, et al. Sodium channel Nav1.8 immunoreactivity in painful human dental pulp. BMC Oral Health 2005;5:5 doi:10.1186/1472-6831-5-5 (Pubitemid 41185293)
91. Bucknill AT, Coward K, Plumpton C, et al. Nerve fibers in lumbar spine structures and injured spinal roots express the sensory neuron-specific sodium channels SNS/PN3 and NaN/SNS2. Spine 2002;27(2):135-140 (Pubitemid 34215551)
92. Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc Natl Acad Sci USA 1998;95(15):8963-8968 (Pubitemid 28350597)
93. Dib-Hajj SD, Tyrrell L, Cummins TR, et al. Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons. FEBS Lett 1999;462(1-2):117-120
94. Dib-Hajj SD, Tyrrell L, Escayg A, et al. Coding sequence, genomic organization, and conserved chromosomal localization of the mouse gene Scn11a encoding the sodium channel NaN. Genomics 1999;59(3)309-318 (Pubitemid 29406912)
95. Cummins TR, Dib-Hajj SD, Black JA, et al. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 1999;19:RC43 1-6
96. Maingret F, Coste B, Padilla F, et al. Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J Gen Physiol 2008;131(3):211-225
97. Blum R, Kafitz KW, Konnerth A. Neurotrophin-evoked depolarization requires the sodium channel Na(V)1.9. Nature 2002;419(6908):687-693
98. Ostman JA, Nassar MA, Wood JN, Baker MD. GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J Physiol 2008;586(4):1077-1087 (Pubitemid 351267347)
99. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci USA 2005;102(26):9382-9387 (Pubitemid 40923572)
100. Wells JE, Bingham V, Rowland KC, Hatton J. Expression of Nav1.9 channels in human dental pulp and trigeminal ganglion. J Endod 2007;33(10):1172-1176
101. Amir R, Michaelis M, Devor M. Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci 1999;19(19):8589-8596 (Pubitemid 30226776)
102. Kovalsky Y, Amir R, Devor M. Subthreshold oscillations facilitate neuropathic spike discharge by overcoming membrane accommodation. Exp Neurol 2008;210(1):194-206
103. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 2006;7(1 Suppl 1):S3-12 • Excellent review concerning VGSCs and their contribution to DRG excitability. (Pubitemid 43106683)
104. Sudoh Y, Cahoon EE, Gerner P, Wang GK. Tricyclic antidepressants as long-acting local anesthetics. Pain 2003;103(1-2):49-55 (Pubitemid 36579084)
105. Tremont-Lukats IW, Challapalli V, McNicol ED, et al. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005;101(6):1738-1749 (Pubitemid 41722151)
106. Challapalli V, Tremont-Lukats IW, McNicol ED, et al. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 2005;4:CD003345 • Very extensive review of the clinical usage of local anaesthetics in neuropathic pain.
107. Hargus NJ, Patel MK. Voltage-gated Na+ channels in neuropathic pain. Expert Opin Investig Drugs 2007;16(5):635-646 (Pubitemid 46723271)
108. Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs 2007;67(9):1265-1289 (Pubitemid 46879094)
109. Dickenson AH, Ghandehari J. Anti-convulsants and anti-depressants. Handb Exp Pharmacol 2007;177:145-177
110. Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 2008;22(1):27-47 (Pubitemid 350243365)
111. Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;48(20):869-872
112. Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9(5):543-554 (Pubitemid 41219786)
113. Magenta P, Arghetti S, Di Palma F, et al. Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies. Neurol Sci 2005;26(4):218-226 (Pubitemid 41447820)
114. Vinik AI, Tuchman M, Safirstein B, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 2007;128(1-2):169-179 (Pubitemid 46216610)
115. Khodorov BI. Batrachotoxin as a tool to study voltage-sensitive sodium channels of excitable membranes. Prog Biophys Mol Biol 1985;45(2):57-148
116. Dunlop J, Bowlby M, Peri R, et al. Ion channel screening. Comb Chem High Throughput Screen 2008;11(7):514-522
117. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 2005;68(6):1611-1622 (Pubitemid 41654345)
118. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 1977;69:497-515 (Pubitemid 8086978)
119. Ragsdale DS, McPhee JC, Scheuer T, Catterall WA. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci USA 1996;93(17):9270-9275 (Pubitemid 26282053)
120. Hanck DA, Makielski JC, Sheets MF. Kinetic effects of quaternary lidocaine block of cardiac sodium channels: a gating current study. J Gen Physiol 1994;103(1):19-43 (Pubitemid 2041189)
121. Zhorov BS, Tikhonov DB. Potassium, sodium, calcium and glutamate-gated channels: pore architecture and ligand action. J Neurochem 2004;88(4):782-799 (Pubitemid 38199299)
122. Tikhonov DB, Zhorov BS. Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J 2005;88(1):184-197 (Pubitemid 40070668)
123. Bruhova I, Tikhonov DB, Zhorov BS. Access and bnding of local anesthetics in the closed sodium channel. Mol Pharmacol 2008; [Epub ahead of print]
124. Valenzuela C, Snyders DJ, Bennett PB, et al. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation 1995;92(10):3014-3024
125. Franqueza L, Longobardo M, Vicente J, et al. Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ Res 1997;81(6):1053-1064 (Pubitemid 27514956)
126. Longobardo M, González T, Navarro-Polanco R, et al. Effects of a quaternary bupivacaine derivative on delayed rectifier K(+) currents. Br J Pharmacol 2000;130(2):391-401 (Pubitemid 30261051)
127. Friederich P, Benzenberg D, Urban BW. Bupivacaine inhibits human neuronal Kv3 channels in SH-SY5Y human neuroblastoma cells. Br J Anaesth 2002;88(6):864-866 (Pubitemid 34618964)
128. Brown DL, Ransom DM, Hall JA, et al. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995;81(2):321-328
129. Maertens C, Cuypers E, Amininasab M, et al. Potent modulation of the voltage-gated sodium channel Nav1.7 by OD1, a toxin from the scorpion Odonthobuthus doriae. Mol Pharmacol 2006;70(1):405-414 (Pubitemid 43920830)
130. Leipold E, Hansel A, Borges A, Heinemann SH. Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3. Mol Pharmacol 2006;70(1):340-347 (Pubitemid 43920824)
131. Xiao Y, Bingham JP, Zhu W, et al. Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain II voltage sensor in the closed confi guration. J Biol Chem 2008;283(40):27300- 27313
132. Wang M, Diao J, Li J, et al. JZTX-IV, a unique acidic sodium channel toxin isolated from the spider Chilobrachys jingzhao. Toxicon 2008; doi:10.1016/j.toxicon.2008.08.018
133. Rosker C, Lohberger B, Hofer D, et al. The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel. Am J Physiol Cell Physiol 2007;293(2):C783-9
134. Liang J, Brochu RM, Cohen CJ, et al. Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain. Bioorg Med Chem Lett 2005;15(11):2943-2947 (Pubitemid 40732252)
135. Williams BS, Felix JP, Priest BT, et al. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7. Biochemistry 2007;46(50):14693-14703 (Pubitemid 350276373)
136. Drizin I, Gregg RJ, Scanio MJ, et al. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain. Bioorg Med Chem 2008;16(12):6379-6386 (Pubitemid 351783416)
137. London C, Hoyt SB, Parsons WH, et al. Imidazopyridines: a novel class of hNav1.7 channel blockers. Bioorg Med Chem Lett 2008;18(5):1696-1701 (Pubitemid 351318238)
138. Kort ME, Drizin I, Gregg RJ, et al. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain. J Med Chem 2008;51(3):407-416 (Pubitemid 351252269)
139. Jarvis MF, Honore P, Shieh CC, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 2007;104(20):8520-8525 (Pubitemid 47175520)
140. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25 (Pubitemid 27046991)
141. Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature 2004;432(7019):855-861 (Pubitemid 40037141)
142. Raschi E, Vasina V, Poluzzi E, De Ponti F. The hERG K+ channel: target and antitarget strategies in drug development. Pharmacol Res 2008;57(3):181-195
143. Vandenberg JI, Walker BD, Campbell TJ. HERG K+ channels: friend and foe. Trends Pharmacol Sci 2001;22(5):240-246
144. Mitcheson JS. hERG potassium channels and the structural basis of drug-induced arrhythmias. Chem Res Toxicol 2008;21(5):1005-1010
145. De Ponti F, Poluzzi E, Cavalli A, et al. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 2002;25(4):263-286 (Pubitemid 34569360)
146. Shah RR. The significance of QT interval in drug development. Br J Clin Pharmacol 2002;54(2):188-202 (Pubitemid 35024944)